Healing at Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression
NCT ID: NCT06877104
Last Updated: 2025-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
156 participants
INTERVENTIONAL
2025-03-13
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Responsive e-Health Intervention for Perinatal Depression in Healthcare Settings
NCT03995316
Postpartum Education Via Artificial Intelligence for Recovery and Loneliness: A Randomized Controlled Trial
NCT07223736
A Text Messaging Intervention to Reduce Perinatal Depression Risk
NCT06117397
Mothers Avoiding Depression Through Empowerment Intervention Trial
NCT01312883
Preventing Postpartum Depression in African American Home Visiting Clients
NCT01175603
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard of care
Routine postpartum care.
No interventions assigned to this group
Healing @ Home Program (H@H 2.0)
Routine postpartum care and the use of an algorithm-based text message support program for six weeks.
Healing @ Home Program (H@H 2.0)
Healing @ Home 2.0 is a clinically used comprehensive technology-based postpartum support program, which provides 24/7 support to individuals through use of a text message based chatbot for six weeks postpartum. Content of H@H 2.0 includes anticipatory guidance regarding physical recovery, infant care and feeding, clinical algorithms to respond to urgent patient needs.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Healing @ Home Program (H@H 2.0)
Healing @ Home 2.0 is a clinically used comprehensive technology-based postpartum support program, which provides 24/7 support to individuals through use of a text message based chatbot for six weeks postpartum. Content of H@H 2.0 includes anticipatory guidance regarding physical recovery, infant care and feeding, clinical algorithms to respond to urgent patient needs.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-identify as a person of color (listed on chart as non-White race and confirmed with patient)
* Able to speak, read and write English
* Age ≥18
* Prenatal care at outpatient practice affiliated with the Hospital of the University of Pennsylvania
* Completion of clinically administered EPDS during inpatient stay
* Routine discharge timing, day 2 or more after vaginal delivery, day 3 or more after cesarean delivery
Exclusion Criteria
* Baby not discharged with mother at postpartum discharge
* Does not have access to a mobile phone
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
March of Dimes
OTHER
University of Pennsylvania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kirstin Leitner
Assistant Professor of Clinical Obstetrics and Gynecology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kirstin Leitner, MD
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
857508
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.